- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Refractory
Total 8953 results
-
University of VirginiaNational Cancer Institute (NCI)Terminated
-
Erimos PharmaceuticalsCompleted
-
SGX Pharmaceuticals, Inc.TerminatedAcute Myelogenous LeukemiaUnited States
-
Spectrum Pharmaceuticals, IncCompletedMantle Cell Lymphoma | Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaUnited States
-
MedImmune LLCCambridge Antibody TechnologySuspendedLymphoma | LeukemiaUnited States
-
Cell GenesysCompleted
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's HospitalCompleted
-
Callisto PharmaceuticalsUnknownAcute Lymphocytic LeukemiaUnited States
-
Callisto PharmaceuticalsCompletedMultiple MyelomaUnited States
-
Astex Pharmaceuticals, Inc.Eisai Inc.CompletedChronic Myelogenous LeukemiaUnited States, Canada
-
University of AlbertaNovartisCompletedRefractory Ascites | Type 2 Hepatorenal SyndromeCanada
-
Seoul National University HospitalUnknownLupus NephritisKorea, Republic of
-
Accentia BiopharmaceuticalsCompleted
-
AbbottCompletedAdenocarcinoma | Prostate CancerCanada, United States, France, Netherlands, United Kingdom
-
University of WashingtonSanofiCompletedProstate CancerUnited States
-
Handok Inc.CompletedProstatic HyperplasiaKorea, Republic of
-
KangLaiTe USACompletedNeoplasms | Solid Tumors Refractory To Standard TherapyUnited States
-
PfizerCompletedDyslipidemia | Hypercholesterolemia | HyperlipidemiaUnited States
-
Keio UniversityTerminated
-
Cooperative Study Group A for HematologyUnknownLymphomaKorea, Republic of
-
Geriatric Oncology ConsortiumSanofiCompletedProstate CancerUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedWegener's Granulomatosis | Microscopic Polyangiitis | Churg-Strauss SyndromeFrance
-
University Hospital, BonnUnknownParoxysmal Atrial Fibrillation
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, France; International...Terminated
-
Gruppo Italiano MEsoteliomaUnknown
-
German AML Cooperative GroupUnknownRelapsed Acute Promyelocytic Leukemia | Refractory Acute Promyelocytic LeukemiaGermany
-
Swedish Medical CenterNovartisCompleted
-
Herlev HospitalEli Lilly and Company; SanofiCompleted
-
London North West Healthcare NHS TrustUnknownGastrointestinal Hemorrhage | Small Bowel Disease | Refractory AnemiaUnited Kingdom
-
Weintraub, Michael I., MD, FACP, FAANDr. Steven P. Cole, PhD. StatisticianCompletedRefractory Carpal Tunnel Syndrome | Neurpathic Pain | NeuromodulatonUnited States
-
Cytogen CorporationUnknownMetastatic Prostate CancerUnited States
-
AbbottCompletedLymphoma, Non-Hodgkin | Hodgkin's LymphomaUnited States
-
AbbottCompletedProstatic NeoplasmsCanada, United States, Spain, Belgium, Australia, Italy, United Kingdom, Germany, France, Sweden, South Africa, Netherlands, Ireland, New Zealand, Greece, Poland, Austria
-
Christian Medical College, Vellore, IndiaUnknownGraft vs Host DiseaseIndia
-
Ophthalmic Consultants of BostonBausch & Lomb IncorporatedUnknownDiabetic Macular EdemaUnited States
-
Urological Sciences Research FoundationAllerganUnknownOveractive BladderUnited States
-
Pharmacyclics LLC.CompletedLymphoma | Non-Hodgkin's LymphomaUnited States
-
University of Sao PauloUnknown
-
Hospices Civils de LyonUnknown
-
Cambridge Antibody TechnologyUnknownLeukemia | Hairy Cell Leukemia | HCLUnited States, Poland, United Kingdom
-
Cambridge Antibody TechnologyUnknownLeukemiaUnited States, Poland
-
University of SalamancaHaematology Service,University Hospital of Salamanca, MªConsuelo del Cañizo...UnknownGraft-vs-Host Disease (GVHD)Spain
-
Shahid Beheshti University of Medical SciencesUnknownDiabetic Macular EdemaIran, Islamic Republic of
-
Karolinska InstitutetMedical Research Council; Schering-PloughCompletedRefractory Myositis
-
Shahid Beheshti University of Medical SciencesCompletedDiabetic Macular EdemaIran, Islamic Republic of
-
McGill UniversityMcGill University Health Centre/Research Institute of the McGill University...Unknown
-
Millennium Pharmaceuticals, Inc.No longer availableMultiple MyelomaUnited States
-
BZL BiologicsCompletedPhase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2Prostatic NeoplasmsUnited States